STOCK TITAN
  1. Home
  2. Sec-filings
  3. KMTS
  4. [Form 4] KESTRA MEDICAL TECHNOLOGIES, LTD. Insider Trading Activity

Kestra Medical Technologies (KMTS) CCO sells 6,275 shares for tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Kestra Medical Technologies Chief Commercial Officer Alfred J. Ford Jr. reported a nondiscretionary sale of 6,275 common shares on 2026-08-04 to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. The shares were sold at a weighted average price of $24.0862, with prices ranging from $23.9000 to $24.5700. Following this tax-related sale, he directly holds 99,564 common shares of Kestra Medical Technologies.

Positive

  • None.

Negative

  • None.
Insider Ford Alfred J Jr
Role Chief Commercial Officer
Sold 6,275 shs ($151K)
Type Security Shares Price Value
Sale Common Shares F1, F2 6,275 $24.0862 $151K
Holdings After Transaction: Common Shares — 99,564 shares (Direct)
Footnotes (2)
  1. F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
  2. F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.5700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Shares sold 6,275 shares Common shares sold by Alfred J. Ford Jr. on 2026-08-04
Weighted average sale price $24.0862 per share Average price for 6,275 common shares sold
Sale price range $23.9000 to $24.5700 Price range of executed sales included in the reported transaction
Shares owned after transaction 99,564 shares Direct common share holdings of Alfred J. Ford Jr. following the sale
sell to cover financial
"represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"tax withholding obligations in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding obligations financial
"transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Kestra Medical (KMTS) report for Alfred J. Ford Jr.?
Kestra Medical reported that Chief Commercial Officer Alfred J. Ford Jr. sold 6,275 common shares on 2026-08-04. This was a nondiscretionary sale to cover tax withholding obligations tied to the vesting and settlement of restricted stock units.

How many KMTS shares did Alfred J. Ford Jr. sell and at what price?
Alfred J. Ford Jr. sold 6,275 Kestra Medical common shares at a weighted average price of $24.0862 per share. Footnotes state the sale prices ranged from $23.9000 to $24.5700 across the executed trades.

Why were Alfred J. Ford Jr.’s Kestra Medical (KMTS) shares sold?
The shares were sold in a nondiscretionary "sell to cover" transaction required to satisfy tax withholding obligations. These obligations arose when Alfred J. Ford Jr.’s restricted stock units vested and settled into common shares.

How many Kestra Medical (KMTS) shares does Alfred J. Ford Jr. own after the sale?
After the reported sale, Alfred J. Ford Jr. directly owns 99,564 Kestra Medical common shares. This post-transaction holding reflects his remaining equity position following the 6,275-share tax-related disposition.

Were the KMTS insider sales by Alfred J. Ford Jr. part of a trading plan?
The transaction is described as a nondiscretionary sell-to-cover for taxes rather than a discretionary trade. The Rule 10b5-1 checkbox for pre-arranged trading plans was not marked as affirmatively used for this reported sale.

What price range applied to Alfred J. Ford Jr.’s KMTS share sale?
The reported weighted average sale price was $24.0862 per share, with individual trades executed in a range from $23.9000 to $24.5700. The insider offers to provide detailed share counts at each specific price upon request.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ford Alfred J Jr
(Last)(First)(Middle)
3933 LAKE WASHINGTON BLVD NE, SUITE 200
(Street)
KIRKLAND WASHINGTON 98033
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/04/2026S(1)6,275D$24.0862(2)99,564D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.5700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
/s/ Traci S. Umberger as attorney-in-fact for Alfred J. Ford Jr.08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR